Dr. LeWarne rose quickly from vice president of product to COO to CEO at RxWare. She now leads a platform that connects data across EHRs, hub systems, specialty pharmacies and patient engagement channels to give pharmaceutical brands a clear understanding of where patients progress and where they stall in the prescription journey. Programs using RxWare have achieved an 82% consent completion rate across active programs, with a 35-fold increase in a rare disease program, and some programs have seen a 40-60% improvement in time to first fill. In the past month, Dr. LeWarne and her team signed two new top-10 pharmaceutical clients. An active pharmacist who left the corporate world during the pandemic to administer Covid-19 vaccinations at CVS Health, she brings a frontline clinical perspective to enterprise technology leadership in pharmaceutical patient access. Before founding HealthFreelance.com and joining RxWare, she served as president of ProCare HospiceCare and vice president of clinical services and sales at ProCare Rx.
